Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey

Eur J Clin Pharmacol. 2018 Jul;74(7):983-984. doi: 10.1007/s00228-018-2460-2. Epub 2018 Apr 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Adverse Drug Reaction Reporting Systems / statistics & numerical data*
  • Aged
  • Aged, 80 and over
  • Aminobutyrates / administration & dosage
  • Aminobutyrates / adverse effects*
  • Angiotensin Receptor Antagonists / administration & dosage
  • Angiotensin Receptor Antagonists / adverse effects*
  • Biphenyl Compounds
  • Drug Combinations
  • Female
  • France
  • Humans
  • Male
  • Middle Aged
  • Pharmacovigilance*
  • Retrospective Studies
  • Tetrazoles / administration & dosage
  • Tetrazoles / adverse effects*
  • Valsartan

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination